SCHEMBL4764017

SCHEMBL4764017

CCn1c(=O)c([N+](=O)[O-])c(C=Cc2cnn(Cc3ccccc3C(F)(F)F)c2)n(CC(C)C)c1=O.c1cc2cc-2c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 14/20 0.40
ADORA2A P29274 13/20 0.40
ADORA1 P30542 13/20 0.40
ADORA3 P0DMS8 7/20 0.40
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
TAS2R8 Q9NYW2 1/20 0.33
SLC16A1 P53985 1/20 0.32
MITF O75030 1/20 0.32
SCD5 Q86SK9 1/20 0.32
GNRHR P30968 1/20 0.32
PLK4 O00444 1/20 0.31
CDK2 P24941 1/20 0.31
IRAK1 P51617 1/20 0.31
RPS6KA3 P51812 1/20 0.31
PLK3 Q9H4B4 1/20 0.31
CSNK1G3 Q9Y6M4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771046 0.93 ADORA2A (0.42) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4771033 0.93 ADORA2A (0.42) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4771540 0.91 ADORA2B (0.40) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4767719 0.89 ADORA2B (0.45) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4767733 0.89 ADORA2B (0.45) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4770831 0.87 ADORA2B (0.43) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4770837 0.87 ADORA2B (0.43) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4897003 0.87 ADORA2B (0.46) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4764008 0.86 ADORA2B (0.41) ADORA2BADORA2AADORA1ADORA3ALDH1A1
SCHEMBL4764018 0.86 ADORA2B (0.41) ADORA2BADORA2AADORA1ADORA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed